73.65
-1.58(-2.10%)
Currency In USD
| Previous Close | 75.23 |
| Open | 75.48 |
| Day High | 76.09 |
| Day Low | 72.82 |
| 52-Week High | 85.25 |
| 52-Week Low | 38.51 |
| Volume | 494,782 |
| Average Volume | 542,660 |
| Market Cap | 3.13B |
| PE | -37.01 |
| EPS | -1.99 |
| Moving Average 50 Days | 78.04 |
| Moving Average 200 Days | 57.36 |
| Change | -1.58 |
If you invested $1000 in Tarsus Pharmaceuticals, Inc. (TARS) since IPO date, it would be worth $3,578.72 as of January 16, 2026 at a share price of $73.65. Whereas If you bought $1000 worth of Tarsus Pharmaceuticals, Inc. (TARS) shares 5 years ago, it would be worth $1,739.08 as of January 16, 2026 at a share price of $73.65.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Tarsus to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025
GlobeNewswire Inc.
Oct 28, 2025 9:00 PM GMT
IRVINE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that it will host a live webcast at 1:30 p.m. PT / 4:30 p.m. ET on Tuesday, November 4, 2025 to report its third quarter 2025 financial r
Tarsus to Report Second Quarter 2025 Financial Results on Wednesday, August 6, 2025
GlobeNewswire Inc.
Jul 30, 2025 9:00 PM GMT
IRVINE, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that it will host a live webcast at 1:30 p.m. PT / 4:30 p.m. ET on Wednesday, August 6, 2025, to report its second quarter 2025 financial
Tarsus to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025
GlobeNewswire Inc.
Apr 24, 2025 9:00 PM GMT
IRVINE, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that it will host a live webcast at 1:30 p.m. PT / 4:30 p.m. ET on Thursday, May 1, 2025, to report its first quarter 2025 financial res